Growth of Clinical Trials and Medical Services
Recently, the market for clinical trial services has been expanding rapidly with an impressive revenue expansion along with the overall growth in the sector. New studies indicate that post 2010 onwards the clinical trial industry has been soaring new heights offering many benefits to the Pharma industry and the clinical service providers. Furthermore, clinical research organizations (CRO) too are playing a crucial role in global drug development from conducting innovative Phase I Study to post marketing studies.
Issues involving increasing prominence of chronic ailments, ageing populations, increased demand for enhanced and new therapies and the growth of biotechnology and pharmaceutical market globally have been generating clinical trials and its market. The globalization of medical development programs and the complexities in trials pertaining to regulatory developments are increasing the need for greater trials and greater numbers of trials. Numerous Pharma companies have been outsourcing clinical trials to attain cost savings, better flexibility and specialist expertise. The emerging clinical trial destinations, comprise CEE countries that include names like China and India that are attaining exceptional growth.
In India, there are eminent CRO’s who conduct regular clinical trials with the help of patient populations, healthy volunteers and special populations and their study portfolio includes the following:
The range of clinical pharmacology studies includes:
- First-in-Man studies
- Single Ascending Dose
- Multiple Ascending Dose
- Food Effect
- Proof of Mechanism
- Proof of Concept
- Drug Interaction Studies
- Pharmacokinetic / Pharmacodynamic Studies
- Thorough QTc (TQTc) Studies
- Biosimilars
Special population studies
- Geriatric Patients
- Renal Impairment
- Hepatic Impairment
- Slow / fast metabolizers
- Asthmatics / COPD
- Postmenopausal women
- Obese / Overweight
- Subjects with Diabetes / Hypertension / Hyperlipidemia / CV risk factors
- Psoriasis / Schizophrenia
Supplementary services
- Regulatory Services
- Central Lab Services
- Bioanalytical Services
- Biometrics & Medical Writing
- Quality Assurance
The latest reports take into account sponsor and CRO perspectives for clinical trial off-shoring and outsourcing. These reports analyze the strength and weakness of this sector and also highlights the chances of future prospects. It has been estimated that the clinical trial market would expand extensive between the years 2010 and 2025.
Clinical trials have helped the medical professionals to arrive at new modes of treatment to already existing chronic ailments. Furthermore, it also helps in assessing the impact of drugs on the human blood level that provides valuable information on the drug development and levels of drug application.
Processing your request, Please wait....
